RxDoctor Payments DataLook up a doctor →

Mark Gittins, DO

Orthopaedic Surgery · Westerville, OHNPI 1598749699

Payments from drug & device makers

$814,659in general payments, 2019–2025

Across 285 payments — averaging $2858.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$390K
  • Nextstep Arthropedix, LLC$283K
  • Lazurite Inc.$120K
  • Medacta USA, Inc.$16K
  • Linkbio Corp$4K
  • Think Surgical, Inc.$808
  • plus $994 from 7 others
$40,313in research payments, 2019–2025

Across 22 payments — averaging $1832.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$40K

What the payments were for

  • Royalty or licence$280,58865%
  • Consulting fees$22,3505%
  • Speaking & faculty fees$115,78527%
  • Travel & lodging$12,1403%
  • Food & beverage$3,0171%
  • Education$430%
  • Gifts$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$814,659 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.

See all orthopaedic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$291,388
Medicare patients
397
Services billed
1,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone64$359
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$140
Hydroxyzine Hcl15$123
Meloxicam30$44
Tramadol Hcl11$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Westerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →